BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28748524)

  • 21. Autoclustering of Non-small Cell Lung Carcinoma Subtypes on (18)F-FDG PET Using Texture Analysis: A Preliminary Result.
    Ha S; Choi H; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
    Nucl Med Mol Imaging; 2014 Dec; 48(4):278-86. PubMed ID: 26396632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic
    Meijer TWH; de Geus-Oei LF; Visser EP; Oyen WJG; Looijen-Salamon MG; Visvikis D; Verhagen AFTM; Bussink J; Vriens D
    Radiology; 2017 May; 283(2):547-559. PubMed ID: 27846378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of
    Manabe O; Ohira H; Hirata K; Hayashi S; Naya M; Tsujino I; Aikawa T; Koyanagawa K; Oyama-Manabe N; Tomiyama Y; Magota K; Yoshinaga K; Tamaki N
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1240-1247. PubMed ID: 30327855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Semiautomatic and Deep Learning-Based Fully Automatic Segmentation Methods on [
    Constantino CS; Leocádio S; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz S; Teixeira R; Neves M; Lúcio P; João C; Costa DC
    J Digit Imaging; 2023 Aug; 36(4):1864-1876. PubMed ID: 37059891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Texture analysis of
    Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability.
    Leijenaar RT; Carvalho S; Velazquez ER; van Elmpt WJ; Parmar C; Hoekstra OS; Hoekstra CJ; Boellaard R; Dekker AL; Gillies RJ; Aerts HJ; Lambin P
    Acta Oncol; 2013 Oct; 52(7):1391-7. PubMed ID: 24047337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy.
    Lee H; Kim H; Choi YS; Pyo HR; Ahn MJ; Choi JY
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance Evaluation of a Semi-automated Method for [
    de Boer SA; Spoor DS; Slart RHJA; Mulder DJ; Reijrink M; Borra RJH; Kramer GM; Hoekstra OS; Boellaard R; Greuter MJ
    Mol Imaging Biol; 2019 Feb; 21(1):159-167. PubMed ID: 29789994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproducibility of the principal component analysis (PCA)-based data-driven respiratory gating on texture features in non-small cell lung cancer patients with
    Fukai S; Daisaki H; Ishiyama M; Shimada N; Umeda T; Motegi K; Ito R; Terauchi T
    J Appl Clin Med Phys; 2023 May; 24(5):e13967. PubMed ID: 36943700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accurate Tumor Delineation
    Sepehri S; Tankyevych O; Iantsen A; Visvikis D; Hatt M; Cheze Le Rest C
    Front Oncol; 2021; 11():726865. PubMed ID: 34733779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential advantages of FDG-PET radiomic feature map for target volume delineation in lung cancer radiotherapy.
    Falahatpour Z; Geramifar P; Mahdavi SR; Abdollahi H; Salimi Y; Nikoofar A; Ay MR
    J Appl Clin Med Phys; 2022 Sep; 23(9):e13696. PubMed ID: 35699200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
    Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of post-injection
    Lovat E; Siddique M; Goh V; Ferner RE; Cook GJR; Warbey VS
    EJNMMI Res; 2017 Dec; 7(1):35. PubMed ID: 28429332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
    Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
    J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Texture analysis of pretreatment [
    Wu WJ; Li ZY; Dong S; Liu SM; Zheng L; Huang MW; Zhang JG
    EJNMMI Res; 2019 Sep; 9(1):89. PubMed ID: 31511990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodal metabolic tumour volume on baseline
    Alipour R; Bucknell N; Bressel M; Everitt S; MacManus M; Siva S; Hofman MS; Akhurst T; Hicks RJ; Iravani A
    J Med Imaging Radiat Oncol; 2021 Oct; 65(6):748-754. PubMed ID: 34318603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.